HB 177 – New Mexico

Status: Inactive / Dead
Year Introduced: 2023
Link: https://www.nmlegis.gov/Legislation/Legislation?chamber=H&legType=B&legNo=177&year=23

House Bill 177 amends Section 26-3-3 NMSA 1978, which is entitled “Drug Product Selection Permitted – Conditions – Exception for Prohibition—Labelling,” with the effect that pharmacists would have wider authority to substitute therapeutically equivalent drugs for drugs that have been prescribed by a medical care provider than is currently granted. HB177 would allow pharmacists to substitute a drug in the same therapeutic class that the pharmacist felt would have a substantially similar effect even if the drug is not a therapeutically equivalent drug.


Return to Database Search

© 2018- The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found